Back to search
FDAFDA · Food and drugs·Recall number D-0025-2019

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.

Published October 24, 2018 · Recall initiated: August 27, 2018

Summary

FDA records drug Class III recall D-0025-2019, published October 24, 2018 and initiated August 27, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 5,790 cartons (526,890 tablets); Lot: Lot # 8508F004A; Exp. 02/20. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Product was distributed throughout the United States.
Lot
Lot # 8508F004A; Exp. 02/20
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53. recalled?

Yes. FDA published recall D-0025-2019 on October 24, 2018. Reported hazard: Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

What should I do if I have this product?

Voluntary: Firm initiated · Letter